Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 36107966.
- Also identified by DOI 10.1371/journal.pone.0273914 and PMC identifier 9477293.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines by national immunization programs in single studies spanning multiple countries and continents are limited but critically needed to answer public health questions on vaccines, such as comparing immune responses to different vaccines and among different populations.
Medical subject headings
- COVID-19
- Vaccines